Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 15 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasms 2 Neoplasm Metastasis 2 Brain Neoplasms 2 Uveal Melanoma 1 Patient Preference 1 Melanoma, Cutaneous Malignant 1 Lymphoma 1 Locally Advanced Melanoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Basal Cell 1

Interventions

HhAntag691 25 Imiquimod 12 Biopsy 12 sonidegib 11 Aminolevulinic Acid 9 cemiplimab 8 Photochemotherapy 8 Nivolumab 8 methyl 5-aminolevulinate 7 Mohs Surgery 7 1-phenyl-3,3-dimethyltriazene 7 Tomography, Optical Coherence 6 Surgical Procedures, Operative 6 Specimen Handling 5 Radiotherapy 5 Itraconazole 5 pembrolizumab 4 daromun 4 Microscopy, Confocal 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 Curettage 4 Standard of Care 3 Niacinamide 3 IPI-926 3 CTLA-4 Antigen 3 3-ingenyl angelate 3 tazarotene 2 talimogene laherparepvec 2 relatlimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × Opdualag × Clear all

NCT06624475 2026-02-05

NEON

University of California, San Diego

Phase 2 Recruiting

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡